-
Views
-
Cite
Cite
Min Kyung Cho, Jung U Shin, Dong Hyun Kim, Hee Jung Lee, Severe atopic dermatitis and concurrent severe hidradenitis suppurativa successfully treated with dupilumab, Clinical and Experimental Dermatology, Volume 47, Issue 12, 1 December 2022, Pages 2303–2305, https://doi.org/10.1111/ced.15387
- Share Icon Share
Abstract
We report a clinical experience of treating concomitant atopic dermatitis and hidradenitis suppurativa (HS) with dupilumab. This report is particularly noticeable in terms of disease severity and treatment duration compared to previous reported cases, suggesting long‐term dupilumab therapy can contribute to disease control even in patients with severe HS.
© 2022 British Association of Dermatologists
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
You do not currently have access to this article.